Research

---

 

 

Book Chapters

Katherine Drabiak, Donald Mullins, Jay Wolfson, Health Policy and Politics, in Government and Politics in Florida 4^th Edition, (J. Edwin Benton ed.) (2025). 

Katherine Drabiak & Zachary Pruitt, Law and Ethics, in American Public Health Association Review Guide for Certified in Public Health Exam 2^nd edition (Karen Liller & Jaime Corvin eds.) (2024).

Katherine Drabiak, Legal Principles Governing Disruptive Technologies in Policing, in Disruption, Ideation and Innovation for Defence and Security (Anthony Masys and Gitanjali Adlakha-Hutcheon eds., 2022).

Katherine Drabiak & Zachary Pruitt, Law and Ethics, in American Public Health Association Review Guide for Certified in Public Health Exam (Karen Liller & Jaime Corvin eds., 2018).

 

Articles

Katherine Drabiak, Demanding or Dodging Death: Reconciling Inconsistencies in Medicine, Notre Dame Journal of Law, Ethics, and Public Policy, forthcoming (invited Symposium edition article).

Katherine Drabiak, Marjorie Fitzsimmons [student], Prithvi Shetty [student], Addressing the Problem of Brain Death Misdiagnosis, Journal of Law, Medicine & Ethics, forthcoming 2025.*

Katherine Drabiak, The Harms of Expanding Physician Assisted Suicide, Health Matrix: Journal of Law-Medicine, forthcoming 2025.

Katherine Drabiak, How Distorting Asylum Law Affects Health and Safety at the Border, Indiana Health Law Review, forthcoming 2025.

Katherine Drabiak, The Problem With Using Medical Boards to Regulate Misinformation, Journal of Legal Medicine 1-16 (2024).*

Gregoire Calon [student] & Katherine Drabiak, How Clinicians Can Respond When Family Members Question a Proxy/Surrogate’s Judgment and Decisional Capacity, 19(3) Clinical Ethics 1-7 (2023).*

Marjorie Fitzsimmons [student] & Katherine Drabiak, Rethinking Epilepsy Diagnosis and Medical Fitness to Drive Laws, 33 Journal of Transport and Health 101723:1-4 (2023).*

Shoaib Khan [student] & Katherine Drabiak, Eight Strategies to Engineer Acceptance of Human Germline Modifications,  Journal of Bioethical Inquiry DOI: 10.1007/s11673-023-10266-3 (2023).*

Sarina Singh [student] & Katherine Drabiak, Parental Rights Laws and the Impact on Mental Health Services and Counseling for Adolescents, Journal of School Health 1746-1751 (2023).*

Katherine Drabiak, Skylar Kyzer [student], Valerie Nemov [student], Issam El Naqa, AI and ML Ethics, Law, Diversity, and Global Impact, 82(973) British Journal of Radiology 20220934: 1-11 (2023).*

Erik Larsen [student] & Katherine Drabiak, Medical Decision-making When the Patient is a Prisoner, Clinical Ethics 1-6 DOI: 10.1177/14777509221133660 (2022).*

Katherine Drabiak, Leveraging Law and Ethics to Promote Safe and Reliable AI/ML in Healthcare, 2(983340) Frontiers in Nuclear Medicine 1-16 (2022).*

Katherine Drabiak, Sacrificing the Public’s Health:  Conspiracies and Trust in the Scientific Enterprise, 15(2) St. Thomas Journal of Law and Public Policy Symposium Edition 1-68 (2022).

Katherine Drabiak, Manipulating the Prescription Drug Market: Spiking Prices, Inducing Demand, and Costs to the Public, Symposium Edition 23(2) DePaul Journal of Health Care Law 1-33 (2022).

Katherine Drabiak, Treating for Two: Reforming Maternal Substance Abuse Policy, 32 Health Matrix: Journal of Law-Medicine 311-397 (2022).

Katherine Drabiak, Framing Germline Modifications to Human Embryos,  102 Boston University Law Review Online Symposium Edition (2022).

Katherine Drabiak, Resolving Physician – Parent Disputes Involving Pediatric Patients, 20(2) Houston Journal of Health Law and Policy 353-410 (2021).*

Emily Ferrell, Katherine Drabiak, Mary Alfano-Torres et al., Planning for Scarcity: Developing an Adult Ventilator Allocation Policy for COVID-19, Clinical Ethics, DOI:10.1177/14777509211016287 (2021).*

Katherine Drabiak, The Intersection of Epidemiology and Legal Authority: COVID-19 Stay At Home Orders, 18(2) Rutgers Journal of Law and Public Policy 1-69 (2021).

Roberto Andorno et al., Geneva Statement on Heritable Human Genome Editing: The Need for Course Correction, 38(4) Trends in Biotechnology 351-354 (2020)* (with Katherine Drabiak). 

Katherine Drabiak, 34(3) The Nuffield Council’s Green Light for Genome Editing Defies Fundamental Human Rights Law, Bioethics 224-227 (2020).*

Katherine Drabiak & Jay Wolfson, What Should Health Care Organizations Do to Reduce Billing Fraud?, 22(3) American Medical Association Journal of Ethics E221-E231 (2020).* 

Katherine Drabiak, Disentangling Dicta: Prince v. Massachusetts, Police Power and Childhood Vaccine Policy, 29 (1) Annals of Health Law and Life Sciences 173-209 (2019).

Katherine Drabiak, Roundup Litigation: Using Discovery to Dissolve Doubt, 4(31) Georgetown Journal of Environmental Law 697-724 (2019).

Katherine Drabiak, Expanding Medication Assisted Treatment is Not the Answer: Flaws in the Substance Abuse Treatment Paradigm, 21(1) Journal of Health Care Law 1-67 (2019).

Katherine Drabiak, Untangling the Promises of Human Genome Editing,  46 Journal of Law, Medicine & Ethics 991-1009 (2018). *

Katherine Drabiak, Emerging Governance of Mitochondrial Replacement Therapy: Assessing Coherence Between Scientific Evidence and Policy Outcomes, 20(1) Journal of Health Care Law 1-61 (2018).

Katherine Drabiak, Dying to Be Fresh and Clean? Assessing Regulatory Shortcomings  Governing Personal Care Products, Cancer Risk, and Epigenetic Damage, 35 Pace Environmental Law Review 75-107 (2017).

Katherine Drabiak, The Impact of a Developing Regulatory Framework Governing LDTs in Precision Oncology: Re-envisioning the Clinical Risk Assessment Paradigm,   13 Journal of Health &  Biomedical Law 1-57 (2017).

Katherine Drabiak, Caveat Emptor: How the Intersection of Big Data and Consumer Genomics Exponentially Increases Informational Privacy Risks, 27 Health Matrix: Journal of Law-Medicine 153-184 (2017).

Katherine Drabiak, Challenging FDA’s Authority to Regulate Autologous Adult Stem Cells for Therapeutic Use: Celltex, Substantial Risks, and the Implications of US v. Regenerative Sciences, 23 Health Matrix: Journal of Law-Medicine, 493-535 (2013).

Katherine Drabiak, New President, New hESC Research Policy:  Comparative International Perspectives and Embryonic Stem Cell Research Laws in France,  32(6) Biotechnology Law Report 349-356 (2013).*    

Katherine Drabiak, Granular Control of EHRs to Overcome Fragmented Disclosure Law: How Policy Choices for  Granularity will Affect Clinical Care, Impact Secondary Use of Health Information, and Alter Risks for Patients and Providers, 10 Indiana Health Law Review 39-73 (2013).

Katherine Drabiak, Sleep Deprived Physicians Considering Modafinil: Using a Controlled Substance For Cognitive Enhancement Gambles With Differential Drug Responses and Violates Ethical And Legal Duties Against Physician Impairment, 13 Journal of Health Care Law 339-366 (2011).

Katherine Drabiak, Waiving Informed Consent to Prenatal Screening and Diagnosis? Problems with Paradoxical Negotiation in Surrogacy Contracts, 39 Journal of Law, Medicine & Ethics 559-564 (2011).*

Katherine Drabiak, Reining In The Pharmacological Enhancement Train: We Should Remain Vigilant About Regulatory Standards For Prescribing Controlled Substances, 39 Journal of Law, Medicine & Ethics 272-279 (2011).*

Katherine Drabiak, Physicians Prescribing “Medicine” for Enhancement: Why We Should Not and Cannot Overlook Safety Concerns, 11 American Journal of Bioethics 17-19 (2011).*

Katherine Drabiak, Lessons from Havasupai Tribe v. Arizona State University Board of Regents: Recognizing Group, Cultural, and Dignitary Harms as Legitimate Risks Warranting Integration into Research Practice, 6 Journal of Health & Biomedical Law 175-225 (2010).

Katherine Drabiak, Legal Regulation of Banking Newborn Blood Spots for Research: How Bearder and Beleno Resolve the Question of Consent, 11 Journal of Health Law & Policy 1-46 (2010).*

Katherine Drabiak, Baby Gender Mentor: Class Action Litigation Calls Attention to a Deficient Federal Regulatory Framework for DTC Genetic Tests, Politicized State Statutory Construction, and a Lack of Informed Consent, 14 Journal of Medicine and Law 71-92 (2010).

Katherine Drabiak, Revisiting the USPTO’s Examination Guidelines for Gene Patents: Congressional Inaction, USPTO Restraint, and Judicial Remedy, 6 Journal of International Biotechnology Law 204-209 (2009).*

Katherine Drabiak, State Codification of Federal Regulatory Ambiguities in Biobanking and Genetic Research: What Can We Learn from New Mexico and Minnesota?, 30 Journal of Legal Medicine 299-327 (2009).*

Jennifer Girod & Katherine Drabiak, A Proposal for Comprehensive Biobank Research Laws to Promote Translational Medicine in Indiana, 5 Indiana Health Law Review 217-250 (2008).

Eric Morrell, Brandon Brown, Ru Qi, Katherine Drabiak, Paul Helft, The Do-Not-Resuscitate Order: Association with Advance Directives, Physician Specialty, and Documentation of Discussion 15 Years After the PSDA, 34 journal of medical ethics 642-647 (2008).*

David Haas, Jaime Renbarger, Eric Meslin, Katherine Drabiak, David Flockhart, Patient Attitudes Toward Genotyping in an Urban Women’s Health Clinic, 112 Obstetrics and Gynecology 1023-1028 (2008).*

Katherine Drabiak, Carole Wegner, Valita Fredland, Paul Helft, Ethics, Law, and Commercial Surrogacy: A Call for Uniformity, 35 Journal of Law, Medicine & Ethics 300-309 (2007).*

* Denotes peer-reviewed or refereed journal.

 

 

Law and Policy Issue Briefings, Technical Reports, and Public Comments

Katherine Drabiak, Policy Memorandum: Senate Bill 1517 and House Bill 2271, Massachusetts State Legislature Public Health Committee, July 12, 2021.

Katherine Drabiak, Policy Memorandum: House Bill 2241, Massachusetts State Legislature Public Health Committee, July 12, 2021.

Katherine Drabiak, Policy Memorandum: Senate Bill 64, Florida State Legislature Health Policy Committee, January 16, 2020.

Katherine Drabiak, Policy Memorandum: House Bill 3999, Massachusetts State Legislature Public Health Committee, December 10, 2019.

 Katherine Drabiak, Policy Memorandum: Senate Bill 2359, Massachusetts State Legislature Public Health Committee, December 10, 2019.

Marcy Darnovsky et al., Civil Society Statement to the Organizers of the Second International Summit on Human Genome Editing, Center for Genetics and Society, November 28, 2018 (with Katherine Drabiak).

Katherine Drabiak, Policy Memorandum: Congressional Appropriations and Human Germline Modification, U.S. Congressional Appropriations Committee, July 24, 2019.

Marcy Darnovsky et al., Civil Society Statement to the Organizers of the Second International Summit on Human Genome Editing, Center for Genetics and Society, November 28, 2018.

Katherine Drabiak, Public Comments to the Singapore Bioethics Advisory Committee on the Topic of Mitochondrial Genome Transfer Technology, Singapore Bioethics Advisory Committee, June 15, 2018.

Katherine Drabiak, FDA Regulation Of Prescription Drug Advertisements: Factors To Consider When Introducing Comparative Effectiveness Claims, White Paper,  Indiana University Center for Bioethics.  2010.

Katherine Drabiak, GINA and Genetic Discrimination, PredictER Law and Policy Update. Indiana University Center for Bioethics, June 11, 2010.

Katherine Drabiak, Human Specimen Collection, Biobanking, and Genetic Research, PredictER Law and Policy Update. Indiana University Center for Bioethics, May 14, 2010.

Katherine Drabiak, Newborn Blood Spot Banking: Approaches to Consent, PredictER Law and Policy Update. Indiana University Center for Bioethics, March 12, 2010.

Katherine Drabiak, Commercialization and Gene Patenting, PredictER Law and Policy Update. Indiana University Center for Bioethics. December 11, 2009.

Katherine Drabiak, Direct-To-Consumer Genetic Testing, PredictER Law and Policy Update. Indiana University Center for Bioethics, December 11, 2009.